Mizuho Initiates Coverage On Minimed Group with Outperform Rating, Announces Price Target of $21
Benzinga Newsdesk 7 months ago
NewsPrice TargetInitiationAnalyst Ratings
Mizuho analyst Anthony Petrone initiates coverage on Minimed Group (NASDAQ:MMED) with a Outperform rating and announces Price Target of $21.
Mizuho analyst Anthony Petrone initiates coverage on Minimed Group (NASDAQ:MMED) with a Outperform rating and announces Price Target of $21.